HUSSMAN STRATEGIC ADVISORS, INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$287,000
-11.4%
7,2000.0%0.06%
-11.9%
Q1 2021$324,000
-78.0%
7,200
-71.2%
0.07%
-82.2%
Q2 2020$1,474,000
+24.7%
25,0000.0%0.38%
+17.9%
Q1 2020$1,182,00025,0000.32%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,136$133,7497.12%
Bellevue Group AG 9,743,900$368,027,1034.88%
M28 Capital Management LP 126,300$4,770,3514.55%
Sicart Associates LLC 246,258$9,301,1653.28%
Camber Capital Management LP 1,925,000$72,7072.49%
Privium Fund Management B.V. 148,807$5,557,9412.11%
Deep Track Capital, LP 1,205,773$45,542,0461.91%
BVF INC/IL 1,121,809$42,370,7261.79%
Orbimed Advisors 1,993,600$75,298,2721.44%
Parkman Healthcare Partners LLC 141,115$5,329,9141.42%
View complete list of IONIS PHARMACEUTICALS INC shareholders